Virtual Event – STAT@JPM: Will 2022 bring biotech renewal?

Editor’s note: A livestream of this event will be embedded below at 1:00 p.m. ET.

The pharmaceutical industry has played a key role in battling the pandemic. But the past year has been a hard one, with biotech stocks underperforming and the Congress pushing hard to create new drug pricing legislation. Come explore what’s happening in biotech and health tech with STAT’s team of ace reporters.

Read the rest…